‘Pretty exciting’: Cancer vaccine breakthrough

A cancer vaccine trial has proven exciting for cancer experts and patients.

Professor Grant McArthur, executive director of the VCCC Alliance, said the trial compared the drug Keytruda on its own with the combination of Keytruda and the vaccine.

“There was a 44 per cent reduction in the cancer coming back,” Professor McArthur told Neil Mitchell.

Press PLAY to hear the exciting breakthrough

The vaccine makes use of the technology used in COVID vaccines such as Moderna and Pfizer to personalise a vaccine for individual cancer patients.

The MRNA technology won’t be used to prevent cancer from forming but will be useful in treating it.

“There are two type of vaccines, there’s the preventative type of vaccine and this so-called therapeutic vaccine,” said Professor McArthur.

Image: iStock.